SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-12-000002
Filing Date
2012-01-03
Accepted
2012-01-03 10:24:45
Documents
4
Period of Report
2011-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT slxcf_8k.htm 8-K 24372
2 PRESS RELEASE slxcf_ex991.htm EX-99.1 25037
3 stellarlogo.jpg GRAPHIC 11772
4 slxcf_ex9910.jpg GRAPHIC 6742
  Complete submission text file 0001354488-12-000002.txt   76299
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 12500409
SIC: 2834 Pharmaceutical Preparations